United States · FDA National Drug Code directory
Lidocaine Hydrochloride and Hydrocortisone Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13925-164_465d3f2b-451a-43eb-83d2-f36ed3bba282
- Product NDC
- 13925-164
- Form
- GEL
- Composition / generic term
- Lidocaine Hydrochloride and Hydrocortisone Acetate
- Labeler
- Seton Pharmaceuticals
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20110617
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 30 mg/g
- HYDROCORTISONE ACETATE — 25 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TUBE in 1 KIT (13925-164-20) / 7 g in 1 TUBE (13925-164-07) · 13925-164-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →